A052260 Stock Overview
Engages in the manufacture and sale of natural materials for cosmetics, nutraceuticals, and regenerative medicines worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
HYUNDAI BIOLAND Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩4,275.00 |
| 52 Week High | ₩7,900.00 |
| 52 Week Low | ₩4,025.00 |
| Beta | 0.46 |
| 11 Month Change | -17.47% |
| 3 Month Change | -22.27% |
| 1 Year Change | -14.67% |
| 33 Year Change | -51.14% |
| 5 Year Change | -59.29% |
| Change since IPO | 144.29% |
Recent News & Updates
Optimistic Investors Push HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260) Shares Up 27% But Growth Is Lacking
Aug 11
Some Investors May Be Worried About HYUNDAI BIOLANDLtd's (KOSDAQ:052260) Returns On Capital
Jul 26Is HYUNDAI BIOLANDLtd (KOSDAQ:052260) A Risky Investment?
May 25Recent updates
Optimistic Investors Push HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260) Shares Up 27% But Growth Is Lacking
Aug 11Some Investors May Be Worried About HYUNDAI BIOLANDLtd's (KOSDAQ:052260) Returns On Capital
Jul 26Is HYUNDAI BIOLANDLtd (KOSDAQ:052260) A Risky Investment?
May 25Subdued Growth No Barrier To HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260) With Shares Advancing 28%
May 03Impressive Earnings May Not Tell The Whole Story For HYUNDAI BIOLANDLtd (KOSDAQ:052260)
Mar 19Should You Buy HYUNDAI BIOLAND Co.,Ltd (KOSDAQ:052260) For Its Dividend?
Apr 12HYUNDAI BIOLAND Co.,Ltd's (KOSDAQ:052260) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?
Mar 08Update: HYUNDAI BIOLANDLtd (KOSDAQ:052260) Stock Gained 14% In The Last Five Years
Feb 15The Returns At HYUNDAI BIOLANDLtd (KOSDAQ:052260) Provide Us With Signs Of What's To Come
Jan 28Tread With Caution Around HYUNDAI BIOLAND Co.,Ltd's (KOSDAQ:052260) 1.5% Dividend Yield
Jan 10HYUNDAI BIOLANDLtd (KOSDAQ:052260) Takes On Some Risk With Its Use Of Debt
Dec 23Are Poor Financial Prospects Dragging Down HYUNDAI BIOLAND Co.,Ltd (KOSDAQ:052260 Stock?
Dec 05
The HYUNDAI BIOLANDLtd (KOSDAQ:052260) Share Price Is Up 55% And Shareholders Are Holding On
Nov 17Shareholder Returns
| A052260 | KR Personal Products | KR Market | |
|---|---|---|---|
| 7D | 1.8% | -0.4% | 2.9% |
| 1Y | -14.7% | -10.9% | -2.8% |
Return vs Industry: A052260 underperformed the KR Personal Products industry which returned -10.9% over the past year.
Return vs Market: A052260 underperformed the KR Market which returned -2.8% over the past year.
Price Volatility
| A052260 volatility | |
|---|---|
| A052260 Average Weekly Movement | 5.9% |
| Personal Products Industry Average Movement | 6.5% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 11.6% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A052260 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A052260's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 320 | Chan-Bok Jeong | www.hyundaibioland.co.kr |
HYUNDAI BIOLAND Co.,Ltd. engages in the manufacture and sale of natural materials for cosmetics, nutraceuticals, and regenerative medicines worldwide. The company’s cosmetics includes whitening, skin protection, moisturizing, anti-aging, sheet mask, and hair and body care products; and functional food ingredients comprising various nutraceuticals and general food raw ingredients.
HYUNDAI BIOLAND Co.,Ltd. Fundamentals Summary
| A052260 fundamental statistics | |
|---|---|
| Market cap | ₩128.25b |
| Earnings (TTM) | ₩8.29b |
| Revenue (TTM) | ₩114.69b |
15.5x
P/E Ratio1.1x
P/S RatioIs A052260 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A052260 income statement (TTM) | |
|---|---|
| Revenue | ₩114.69b |
| Cost of Revenue | ₩70.09b |
| Gross Profit | ₩44.60b |
| Other Expenses | ₩36.31b |
| Earnings | ₩8.29b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 276.32 |
| Gross Margin | 38.89% |
| Net Profit Margin | 7.23% |
| Debt/Equity Ratio | 23.5% |
How did A052260 perform over the long term?
See historical performance and comparisonDividends
0.8%
Current Dividend Yield13%
Payout RatioDoes A052260 pay a reliable dividends?
See A052260 dividend history and benchmarks| HYUNDAI BIOLANDLtd dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Apr 21 2025 |
| Days until Ex dividend | 33 days |
| Days until Dividend pay date | 148 days |
Does A052260 pay a reliable dividends?
See A052260 dividend history and benchmarks